ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

Carcinogenesis Program Direction Changes Near for Extramural research; Workshop Topics Listed

April 22, 1977

PRI’s Frederick Fee $903,866 For First Six Months Of New Contract

September 2, 1988

Study Finds No Benefit From CT In Lung Cancer; Advocacy Group Alleges “Delaying Tactic.”

March 9, 2007

Proposed Regulations for Center Grants In Federal Register

October 29, 1976

NCAB Approves Addition Of Two New Organ Systems

February 14, 1986

NCCS Networker Volume 3 Issue 2, Spring 1989

April 13, 1989